Intraventricular vancomycin for treatment of shunt-associated ventriculitis
- 1 February 1987
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 19 (2) , 249-253
- https://doi.org/10.1093/jac/19.2.249
Abstract
Twenty episodes of shunt-associated ventriculitis caused by staphylococci or streptococci were treated with intraventricular vancomycin together with removal of the shunt and insertion of an external drain. Systemic antibiotics given concurrently included intravenous vancomycin or flucloxacillin. All the patients responded to therapy although five had re-infections and one had a relapse. Four patients were treated solely with intrathecal vancomycin. We now use intraventricular vancomycin alone for ‘blind’ treatment of uncomplicated shunt-associated infections when Gram-positive cocci are seen in the ventricular CSF.Keywords
This publication has 4 references indexed in Scilit:
- Sensitivity patterns of coagulase-negative staphylococci from neonatesJournal of Antimicrobial Chemotherapy, 1986
- Clinical pharmacology and efficacy of vancomycin in pediatric patientsThe Journal of Pediatrics, 1980
- Vancomycin treatment of cerebrospinal fluid shunt infectionsJournal of Neurosurgery, 1979
- A NEW TYPE OF PENICILLIN RESISTANCE OF STAPHYLOCOCCUS AUREUSThe Lancet, 1977